share_log

VERU ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 6, 2023 in the Class Action Filed on Behalf of Veru Inc. Shareholders

VERU ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 6, 2023 in the Class Action Filed on Behalf of Veru Inc. Shareholders

警報:克萊因律師事務所宣布代表 VERU Inc. 股東提交的集體訴訟中的主要原告截止日期為 2023 年 2 月 6 日
PR Newswire ·  2023/01/17 06:00

NEW YORK, Jan. 17, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Veru Inc. (NASDAQ: VERU) alleging that the Company violated federal securities laws.

紐約, 2023 年一月十七日 /PRNewswire/-克萊因律師事務所宣布,已代表 Viru Inc.(納斯達克代碼:VERU)的股東提出集體訴訟投訴,指稱該公司違反了聯邦證券法。

This lawsuit is on behalf of all investors who purchased or otherwise acquired Veru Inc. common stock between May 11, 2022 and November 9, 2022, inclusive.
Lead Plaintiff Deadline: February 6, 2023
No obligation or cost to you.

此訴訟代表所有購買或以其他方式獲得 Vuru Inc. 普通股的投資者 2022年5月11日2022年11月9日,包容性。
領導原告截止日期: 2023年2月6日
對您沒有任何義務或成本。

Learn more about your recoverable losses in VERU:

了解更多有關您在 VERU 中可恢復的損失的信息:

Veru Inc. NEWS - VERU NEWS

維魯公司新聞-最新消息

CLASS ACTION CASE DETAILS: The filed complaint alleges that Veru Inc. made materially false and/or misleading statements and/or failed to disclose that: 1) the Company had withheld material adverse facts about the data from the sabizabulin Phase 3 trial and the Company's interactions with the United States Food and Drug Administration; 2) defendants misled Veru's shareholders to believe that the data from the sabizabulin Phase 3 trial was sufficient to support Emergency Use Authorization ("EUA") and even the submission of a New Drug Application without any further studies; and 3) the Company's filings concealed the true risks faced by Veru in gaining approval for its EUA request.

集體訴訟案件詳情: 提起的投訴指,Veru Inc. 作出重大虛假和/或誤導性陳述和/或未能披露:1)公司已經拒絕了來自 Sabizabulin 第三期試驗的數據以及公司與美國食品藥品管理局的互動的重大不良事實;2)被告誤導 Veru 的股東認為來自 Sabizabulin 第 3 期授權的數據足以支持緊急試驗(「緊急使用」)甚至在沒有任何進一步研究的情況下提交新藥申請; 和 3)公司的文件掩蓋了 Vuru 在獲得其 EUA 請求批准時所面臨的真實風險。

WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Veru you have until February 6, 2023 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

這對您作為股東意味著什麼: 如果您在 Veru 遭受了損失,那麼您必須直到 2023年2月6日 向法院呈請領導原告人的身份。您在任何恢復中分享的能力並不需要您擔任主要原告。

NO COST TO YOU: If you purchased Veru securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.

您無需支付任何費用:如果您在相關期間購買了 Vuru 證券,您可能有資格獲得賠償,而無需支付任何自付費用。

HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the VERU lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click this link:

如何保障您的財務利益: 如需有關 VERU 訴訟的其他資訊,請致電 212-616-4899 或按一下此連結聯絡:

ABOUT KLEIN LAW FIRM
關於克萊因律師事務所

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. The Klein Law Firm is a boutique litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced attorneys have achieved superior results for our clients with a personalized focus. Attorney advertising. Prior results do not guarantee similar outcomes.

J· 克萊因(J.Klein)代表投資者並參與全國各地涉及金融欺詐的證券訴訟。Klein 律師事務所是一家精品訴訟事務所,在證券法、企業融資和商業訴訟等廣泛領域擁有豐富經驗。自 2011 年以來,我們經驗豐富的律師以個性化的重點為我們的客戶取得了卓越的成績。律師廣告。先前的結果不能保證類似的結果。

CONTACT:
J. Klein, Esq.
535 Fifth Avenue
4th Floor
New York City, NY 10017
[email protected]
Telephone: (212) 616-4899

聯絡人:
J. 克萊因,埃斯基。
第五大道 535 號
四樓
紐約市, 紐約
[電子郵件保護]
電話:

SOURCE The Klein Law Firm

來源克萊因律師事務所

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論